Repligen (RGEN) Capital Expenditures (2010 - 2026)

Repligen (RGEN) has reported Capital Expenditures for 17 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 24.88% year-over-year to $5.3 million in Q2 2026; TTM through Jun 2026 was $22.9 million, a 1.24% decrease from a year earlier, with the FY2025 full-year figure at $23.5 million, down 8.4% from the prior year.
• Capital Expenditures was $5.3 million for Q2 2026 at Repligen, up from $4.7 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $27.2 million in Q1 2022 and troughed at $3.6 million in Q1 2025.
• A 5-year average of $10.0 million and a median of $8.2 million in 2023 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 258.7% in 2022 and sank 68.72% in 2023, its largest moves.
• Over 5 years, Capital Expenditures stood at $20.4 million in 2022, then sank by 45.77% to $11.1 million in 2023, then plunged by 50.03% to $5.5 million in 2024, then soared by 47.17% to $8.2 million in 2025, then sank by 34.58% to $5.3 million in 2026.
• The last three Capital Expenditures figures came in at $5.3 million (Q2 2026), $4.7 million (Q1 2026), and $8.2 million (Q4 2025), per Business Quant data.